Atezolizumab vs Epcoritamab

## Atezolizumab vs Epcoritamab: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Epcoritamab**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Epcoritamab — N/A.

## Chemical Properties

**Type**: Atezolizumab — Antibody; Epcoritamab — Antibody.